Eysuvis Dosage
Generic name: LOTEPREDNOL ETABONATE 2.5mg in 1mL
Dosage form: ophthalmic suspension
Drug class: Ophthalmic steroids
Medically reviewed by Drugs.com. Last updated on Mar 11, 2025.
Dosage Information
Instill one to two drops of EYSUVIS into each eye four times daily for up to two weeks. This product should only be renewed after examination under magnification such as a slit lamp and evaluation of the intraocular pressure..
Administration Instructions
Instruct patient to wash hands well before each use. Shake for two to three seconds before using.
If the patient is using other eye drops in addition to EYSUVIS, advise the patient to wait at least 5 minutes between instillation of EYSUVIS and other eye drops.
If a dose is missed, take the missed dose when remembered.
Frequently asked questions
More about Eysuvis (loteprednol ophthalmic)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (8)
- Drug images
- Side effects
- During pregnancy
- FDA approval history
- Drug class: ophthalmic steroids
- Breastfeeding
- En español
Patient resources
Other brands
Lotemax, Alrex, Lotemax SM, Inveltys
Professional resources
Other brands
Related treatment guides
See also:
Chantix
Chantix is a smoking cessation medicine used with behavior modification and counseling to help you ...
Restasis
Restasis is used to treat chronic dry eye that may be caused by inflammation. Learn about side ...
Ozempic
Learn about Ozempic (semaglutide) for type 2 diabetes treatment, weight management, cardiovascular ...
Xiidra
Xiidra (lifitegrast 5%) is an eye drop solution that is used twice daily in each eye to treat the ...
Miebo
Miebo (perfluorohexyloctane) is used to treat the signs and symptoms of dry eye disease. Includes ...
Cequa
Cequa (cyclosporine ophthalmic) is a prescription eye drop used to treat chronic dry eye from ...
Lotemax
Lotemax and Lotemax SM (loteprednol etabonate) are corticosteroid medications used to help treat ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
